BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 2, 2013
View Archived Issues
Researchers uncover the mechanism behind malaria parasite sensitivity to spiroindolone-based drugs
Read More
Alemtuzumab treatment maintains efficacy in phase III extension study
Read More
Sernova receives Canadian funding for Sertolin technology
Read More
Pharmacodynamics of new rituximab biosimilar evaluated
Read More
Chinese researchers present new protein kinase inhibitors for cancer
Read More
Biovista and Dart Therapeutics enter collaboration
Read More
Researchers evaluate inflammatory and immune system biomarkers in chronic prostatitis
Read More
Omeros set to advance lead PDE10 inhibitor to phase II
Read More
Myriad Genetics to conduct HRD testing for PharmaMar
Read More
NICE recommends two treatments for lung infection in cystic fibrosis
Read More
Oncodesign to apply Nanocyclix technology to Sanofi kinase target
Read More
GNbAC-1 is safe and well tolerated in phase IIa trial
Read More
University of New Mexico to collaborate with Biosortia Pharmaceuticals
Read More
Soligenix cleared to begin phase II study of SGX-942
Read More
CureVac commences phase IIb trial of mRNA-based prostate cancer vaccine
Read More
A team of German researchers disclose novel antimalarial agents
Read More
Eisai obtains FDA approval for new formulation of AcipHex
Read More
Single nucleotide polymorphisms in MKL1 and CYP3A5 genes are associated with risk of CI-AKI
Read More
KU-046 improves cognitive function in vivo
Read More
Anaeropharma Science begins first-in-human trial of APS-001-F
Read More
Anthera Pharmaceuticals begins phase III CHABLIS-SC1 trial in lupus
Read More
Both primary endpoints met in pivotal study of Androxal
Read More
Novel phosphodiesterase inhibitors patented by Lundbeck
Read More
Japanese scientists design new ACC2 inhibitors
Read More
Novel Mnk1 inhibitors identified at Bayer
Read More
Invokana approved by the FDA for type 2 diabetes
Read More
NDA filed for hepatitis C candidate simeprevir
Read More